T1	Participants 551 657	Since July 1996, 198 patients with non-operable NSCLC and measurable disease without previous chemotherapy
T2	Participants 106 149	advanced non-small-cell lung cancer (NSCLC)
T3	Participants 153 164	multicenter
T4	Participants 952 1140	Eligibility criteria included WHO performance status 0-2, documented inoperable stage IIIA and IIIB, IV, no brain metastasis, no prior chemotherapy and adequate renal and hepatic function.
